By BY CARL ZIMMER from NYT Health https://ift.tt/2S3JZhJ
CureVac’s mRNA vaccine reaches an efficacy level of just 47 percent in a clinical trial.
By BY CARL ZIMMER from NYT Health https://ift.tt/2S3JZhJ
By BY CARL ZIMMER from NYT Health https://ift.tt/2S3JZhJ
Subscribe to:
Post Comments (Atom)
Post a Comment Blogger Facebook
Thanks for commenting. I hope you will do again.